Niagen Bioscience (NAGE) Capital Expenditures (QoQ) (2011 - 2020)
Powered by 
Analysis
Niagen Bioscience (NAGE) Capital Expenditures (QoQ) (2011 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Niagen Bioscience | 251.05 Mn | 184.31 Mn | 19.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 513.33% |
| Mar 31, 2020 | -94.64% |
| Dec 31, 2019 | 80.65% |
| Sep 30, 2019 | 124.64% |
| Jun 30, 2019 | -71.13% |
| Mar 31, 2019 | 2,290.00% |
| Dec 31, 2018 | -72.97% |
| Sep 30, 2018 | -96.68% |
| Jun 30, 2018 | 591.30% |
| Mar 31, 2018 | -45.42% |
| Dec 30, 2017 | -48.87% |
| Sep 30, 2017 | 333.83% |
| Jul 1, 2017 | -17.90% |
| Apr 1, 2017 | -71.27% |
| Dec 31, 2016 | -20.55% |
| Oct 1, 2016 | 230.79% |
| Jul 2, 2016 | 1,190.35% |
| Apr 2, 2016 | -96.48% |
| Mar 30, 2013 | -31.16% |
| Dec 29, 2012 | 596.19% |